James Topper Buys 660 Shares of NewAmsterdam Pharma (NASDAQ:NAMS) Stock
MarketBeat
NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Get Free Report) Director James Topper purchased 660 shares of the business's stock in a transaction dated Monday, September 15th. The shares were acquired at an average price of $23.70 per share, for a total transaction of $15,642.00. Following the acquisition, the director owned 3,028,524 shares of the company's stock, valued at $71,776,018.80. This trade represents a 0.02% increase in their position. The purchase was disclosed in a document filed with the SEC, which is accessible through the SEC website.
NASDAQ:NAMS